PTC Therapeutics Inc

PTCT

Company Profile

  • Business description

    PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

  • Contact

    500 Warren Corporate Center Drive
    WarrenNJ07059
    USA

    T: +1 908 222-7000

    E: [email protected]

    https://www.ptcbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    991

Stocks News & Analysis

stocks

ASX biotech expands diagnostics portfolio after FDA approval

FDA nod adds another growth driver for ASX share.
stocks

Is it time to bail on Australian stocks?

Is your home bias costing your portfolio better returns?
stocks

ASX share undervalued despite margin woes

Short term margin pressure yet shares remain undervalued on improved outlook.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,874.5025.200.28%
CAC 408,103.4413.160.16%
DAX 4025,425.4623.180.09%
Dow JONES (US)52,093.11328.09-0.63%
FTSE 10010,691.5233.390.31%
HKSE24,713.7846.540.19%
NASDAQ25,981.57204.84-0.78%
Nikkei 22563,923.00438.900.69%
NZX 50 Index13,622.72138.501.03%
S&P 5007,585.7334.25-0.45%
S&P/ASX 2008,696.5024.000.28%
SSE Composite Index3,891.6027.320.71%

Market Movers